Becker's Healthcare June 12, 2024
Value-based strategy helped Humana improve outcomes and reduce costs for patients with chronic kidney disease and end-stage renal disease.
The company published an issue brief detailing its strategy for value-based kidney care June 11.
Here are five things to know from the brief:
- As engagement with value-based programs has increased, the medical expense ratios among Humana members has dropped. In 2019, Humana patients with chronic kidney disease had a medical expense ratio of over 100%. This number dropped to 88% in 2024.
- Patients with chronic kidney disease and end-stage renal disease were more likely to follow up with nephrologists when compared to patients in a fee-for-service-only...